Oncology in Clinical Practice is a vital resource in the field of oncology, published by VIA MEDICA in Poland. This peer-reviewed journal, with ISSN 2450-1654 and E-ISSN 2450-6478, aims to bridge the gap between clinical practice and cancer research, providing a platform for the dissemination of original research, reviews, and case studies. Since its inception in 2019, the journal has featured significant contributions to the understanding of cancer treatment and patient care, although it currently holds a Q4 ranking in Oncology with a Scopus rank of #313/404 and a 22nd percentile in the Medicine _ Oncology category. Though it is not an open-access journal, its content is invaluable for oncologists, researchers, and students, offering critical insights and advancements in clinical approaches to cancer management. With a commitment to enhancing patient outcomes through clinical evidence, Oncology in Clinical Practice serves as an essential reference for those dedicated to the fight against cancer.

Imagerie de la Femme, published by ELSEVIER MASSON, is a pivotal journal in the field of women’s health and surgical practices, holding an ISSN of 1776-9817 and an E-ISSN of 2214-8485. Established in 2005 and converging through to 2024, this journal is dedicated to disseminating high-quality research and innovative findings that contribute to the understanding and advancement of surgical techniques and imaging modalities specifically tailored to women. Despite its current Q3 ranking in Surgery and Scopus rank of 536/551, the journal is increasingly recognized for its focus on emerging trends and critical issues within the discipline. As a scholarly platform, it offers an essential resource for researchers, healthcare professionals, and students alike, promoting knowledge exchange and fostering advancements in the nuanced realm of female surgical health. With its commitment to enhancing clinical practice and patient outcomes, Imagerie de la Femme plays an important role in shaping future research and educational efforts in this vital area of medicine.

Breast Cancer-Basic and Clinical Research is a premier open access journal published by SAGE Publications Ltd, dedicated to advancing the understanding and treatment of breast cancer through a comprehensive approach that integrates basic and clinical research findings. Since its inception in 2008, this journal has aimed to serve as a vital platform for researchers, healthcare professionals, and students in the fields of oncology and cancer research, providing them with timely access to significant new research, clinical trials, and innovative methodologies. With its current rankings placing it in the Q3 quartile for Cancer Research and Oncology, it reflects a steady commitment to quality and relevance, ranking #167/404 in Medicine - Oncology and #133/230 in Biochemistry, Genetics and Molecular Biology - Cancer Research as of 2023. The journal is designed to foster dialogue and collaboration across disciplines, enabling advancements in therapeutic strategies and patient care. Researchers and professionals will find it an invaluable resource as it continues to push the frontiers of knowledge in breast cancer research.

Current Breast Cancer Reports is a vital academic journal published by Springer that focuses on the latest research and advancements in the field of breast cancer. With its ISSN 1943-4588 and E-ISSN 1943-4596, this journal serves as an essential resource for oncologists, researchers, and healthcare professionals dedicated to improving diagnosis and treatment strategies for breast cancer. Spanning from 2009 to 2024, it provides a platform for high-quality, peer-reviewed articles that encompass a range of topics, including molecular biology, clinical trials, and innovative therapeutic approaches. Although it is currently classified in the Q3 category in Oncology and is positioned in the 29th percentile, the journal remains committed to elevating its academic impact and contributing meaningfully to the ongoing fight against breast cancer. As it seeks to disseminate critical findings and foster collaboration within the scientific community, Current Breast Cancer Reports is poised to be an indispensable tool for anyone keen on advancing the field.

npj Breast Cancer, published by NATURE PORTFOLIO, stands at the forefront of breast cancer research as an esteemed open access journal since 2015. With its impressive trajectory, the journal has garnered a notable impact within the academic community, reflecting a Q1 ranking in prestigious categories such as Oncology, Pharmacology, and Radiology for 2023. Based in the United Kingdom and indexed under E-ISSN 2374-4677, npj Breast Cancer aims to disseminate cutting-edge research that fosters innovation in prevention, diagnosis, and treatment of breast cancer, thereby addressing one of the most pressing health issues of our time. Its placement within Scopus rankings, including a remarkable 19th position in Pharmacology and a percentile ranking in the 90th range for Radiology and Oncology, highlights its significance as a key resource for researchers, healthcare professionals, and policy-makers dedicated to advancing cancer care. Emphasizing accessibility and high-quality content, npj Breast Cancer provides an influential platform for interdisciplinary collaboration and discovery in the ongoing battle against breast cancer.

Gland Surgery, an esteemed journal published by AME PUBLISHING COMPANY, is at the forefront of surgical research, particularly focusing on advancements in gland-related surgeries and their clinical implications. With an ISSN of 2227-684X and an E-ISSN of 2227-8575, this open-access journal provides a platform for disseminating high-quality research and insights into the intricate aspects of surgical practices, ranking in the Q2 category in Surgery as of 2023. As evidenced by its Scopus ranking at #153 out of 551 in the Medicine_Surgery field, Gland Surgery delivers valuable contributions to the global medical community, promoting the exchange of knowledge and innovative techniques. Operating from Hong Kong, China, and converging its excellence from 2016 to 2024, the journal is a critical resource for researchers, clinicians, and students keen on exploring the latest developments in the field. By fostering an open dialogue among professionals, Gland Surgery is accessible to a diverse audience seeking to enhance their understanding and practice in gland surgery.

Radiologic Clinics of North America, published by W B Saunders Co-Elsevier Inc, stands as a pivotal resource in the field of medical imaging and radiology. With a solid history dating back to 1963 and converging years extending to 2024, this journal has established itself as a reputable platform for original research, comprehensive reviews, and insightful discussions that advance the knowledge and practice of radiology, nuclear medicine, and imaging. Holding a Q2 classification in both the miscellaneous medicine and radiology categories and positioned within the 56th percentile among its peers, its contributions are vital for both academic research and clinical applications. Although it does not offer open access, the journal remains accessible through institutional subscriptions and is a must-read for researchers, healthcare professionals, and students keen on the latest developments in radiological practices. With a dedicated editorial board and a commitment to the highest academic standards, Radiologic Clinics of North America continues to shape the future of the medical imaging field.

Breast Cancer-Targets and Therapy is a leading journal in the field of oncology, published by DOVE MEDICAL PRESS LTD in New Zealand. Established as an Open Access journal in 2009, it offers a platform for researchers and healthcare professionals to disseminate innovative findings and therapeutic strategies related to breast cancer. With an impressive ranking in the Q2 category of oncology journals as of 2023, and placed at Rank #203/404 in the Scopus database, this journal facilitates the exchange of high-quality research aimed at improving patient outcomes and advancing clinical practices. Covering a wide array of topics from basic research to clinical trials, Breast Cancer-Targets and Therapy plays a crucial role in bridging the gap between scientific discovery and practical application. Researchers, professionals, and students alike will find the journal a valuable resource for the latest advancements and best practices in breast cancer treatment.

The Journal of Mammary Gland Biology and Neoplasia is an esteemed academic journal published by Springer/Plenum Publishers, focusing on cutting-edge research in the fields of cancer biology and oncology. With an ISSN of 1083-3021 and an E-ISSN of 1573-7039, this journal serves as a vital resource for researchers and practitioners aiming to deepen their understanding of mammary gland biology and its implications in neoplasia. The journal boasts a commendable impact factor, being categorized in the Q2 quartile for both Cancer Research and Oncology as of 2023, indicating its significant influence in these critical areas of study. Additionally, its ranking within Scopus reveals its competitiveness, with a rank of 154 out of 404 in Medicine - Oncology and 128 out of 230 in Biochemistry, Genetics and Molecular Biology - Cancer Research. Although the journal does not operate under an open access model, it continues to deliver vital insights and findings from 1996 to the present and is committed to advancing knowledge and fostering discussion around mammary gland health and cancer. Researchers, healthcare professionals, and students will find invaluable contributions within its pages, making it a cornerstone publication in the pursuit of cancer research and treatment.

BREAST CANCER RESEARCH, published by BMC, is a prestigious open-access journal dedicated to advancing the field of oncology with a specific focus on breast cancer. Since its inception in 1999, the journal has established itself as a leading platform for disseminating high-quality research, with an impressive impact factor and recognition in the Q1 category for both Cancer Research and Oncology as of 2023. The journal is ranked 45th out of 404 in the field of Medicine _ Oncology and 37th out of 230 in Biochemistry, Genetics and Molecular Biology _ Cancer Research, placing it in the top echelons of research quality and relevance at 88th and 84th percentiles, respectively. BREAST CANCER RESEARCH is committed to facilitating rapid and open access to groundbreaking findings, making it an invaluable resource for researchers, healthcare professionals, and students striving to enhance their understanding of breast cancer mechanisms, treatments, and prevention strategies. With its base in the United Kingdom, the journal continues to foster international collaborations and discussions aimed at improving patient outcomes and enriching cancer research worldwide.